ClearPoint Neuro, Inc.
CLPT
$11.26
$0.010.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.07% | 14.11% | 40.96% | 32.07% | 40.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.07% | 14.11% | 40.96% | 32.07% | 40.60% |
| Cost of Revenue | 7.68% | 7.58% | 31.58% | 1.63% | 39.58% |
| Gross Profit | 13.41% | 18.66% | 48.09% | 59.56% | 41.32% |
| SG&A Expenses | 29.43% | 15.94% | 16.77% | -0.68% | 3.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.56% | 16.14% | 24.72% | -3.70% | 6.37% |
| Operating Income | -46.18% | -19.08% | -5.62% | 33.54% | 26.19% |
| Income Before Tax | -45.44% | -16.61% | -3.43% | 37.49% | 26.35% |
| Income Tax Expenses | 20.00% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.34% | -16.61% | -3.43% | 37.49% | 26.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.34% | -16.61% | -3.43% | 37.49% | 26.08% |
| EBIT | -46.18% | -19.08% | -5.62% | 33.54% | 26.19% |
| EBITDA | -52.53% | -18.59% | -3.57% | 35.40% | 28.84% |
| EPS Basic | -33.46% | -4.05% | 7.63% | 44.06% | 28.62% |
| Normalized Basic EPS | -33.63% | -4.10% | 7.62% | 44.06% | 28.89% |
| EPS Diluted | -33.46% | -4.05% | 7.63% | 44.06% | 28.62% |
| Normalized Diluted EPS | -33.63% | -4.10% | 7.62% | 44.06% | 28.89% |
| Average Basic Shares Outstanding | 8.91% | 12.05% | 12.02% | 11.73% | 3.53% |
| Average Diluted Shares Outstanding | 8.91% | 12.05% | 12.02% | 11.73% | 3.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |